RA Capital Management’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $117M | Buy |
12,198,625
+1,561,335
| +15% | +$14.9M | 1.97% | 15 |
|
|
2025
Q1 | $98.9M | Hold |
10,637,290
| – | – | 1.65% | 15 |
|
|
2024
Q4 | $148M | Buy |
10,637,290
+220,681
| +2% | +$3.07M | 1.97% | 13 |
|
|
2024
Q3 | $245M | Hold |
10,416,609
| – | – | 2.82% | 7 |
|
|
2024
Q2 | $167M | Hold |
10,416,609
| – | – | 2.2% | 13 |
|
|
2024
Q1 | $171M | Buy |
10,416,609
+3,180,155
| +44% | +$52.2M | 2.17% | 10 |
|
|
2023
Q4 | $100M | Hold |
7,236,454
| – | – | 1.57% | 15 |
|
|
2023
Q3 | $99.6M | Hold |
7,236,454
| – | – | 1.96% | 11 |
|
|
2023
Q2 | $123M | Hold |
7,236,454
| – | – | 2.33% | 10 |
|
|
2023
Q1 | $116M | Hold |
7,236,454
| – | – | 2.63% | 11 |
|
|
2022
Q4 | $55M | Hold |
7,236,454
| – | – | 1.12% | 27 |
|
|
2022
Q3 | $63.6M | Hold |
7,236,454
| – | – | 1.36% | 24 |
|
|
2022
Q2 | $51.7M | Hold |
7,236,454
| – | – | 1.38% | 23 |
|
|
2022
Q1 | $77.4M | Hold |
7,236,454
| – | – | 1.69% | 14 |
|
|
2021
Q4 | $102M | Hold |
7,236,454
| – | – | 1.8% | 13 |
|
|
2021
Q3 | $127M | Buy |
+7,236,454
| New | +$127M | 1.76% | 18 |
|